Capital Wealth DailyThe End-of-Week Recap, from the August 21 and 22 Wall Street Journals. Treasury tried to buy its own bonds back, and the ten-year closed at 4.737% anyway. Walmart saw the consumer get careful. Moderna went up 177% in an afternoon. The turbines behind our power thesis cracked. And the betting crowd stopped pricing rate cuts and started pricing a hike.

Treasury Secretary Scott Bessent said buybacks could double to more than $4 billion an operation. The ten-year Treasury yield rose anyway and settled Friday at 4.737%. The Dow lost 704 points Thursday and took 518 of them back Friday. The S&P 500 still finished the week down 1.4%. The Journal’s Greg Ip named the problem. Treasurys no longer carry a safety premium. They carry an absorption premium. Investors are being paid to take the supply, not rewarded for the shelter.
Our TakeA yield rising on supply punishes long bonds without paying you for the risk. Action: the ladder stays short, floating-rate Treasuries (USFR) join the income sleeve, and inflation-linked bonds keep the long horizon. Nothing sold on stocks.
Treasury tried to buy its own bonds, and the 10-year broke 4.7% anyway. The safe haven faded.
Walmart sees 150 million wallets, and they are tired. Slowest growth in six years.
Moderna rose 177% in a day. We are buying the partner, not the lottery ticket.
Prediction markets stopped pricing cuts and started pricing hikes.
The turbines behind the off-grid power thesis are cracking at 3 of 4 U.S. sites. We're watching, not selling.

Keep the boat you play with separate from the boat you eat with. The eighth-grader already figured that out.

“In America, people get a second chance. They don’t get a third.” The plan exists to make sure you never need one.

Buy the dog, not the owner. It applies to puppies, podcast stock tips, and your brother-in-law’s favorite fund.

A fuel tax and a channel shift are not a recession. We hold Walmart (WMT) through a 9% drop on a guidance raise.

The cheapest time to fix it is before open enrollment in ten weeks. Pick the plan design, compare your spouse's plan, and protect the 401(k) rate.

Cost is the one thing you control, and Bogle proved it. The catch is that “the index” is now a technology bet nobody chose.

If your income plan assumes rates fall, the crowd has quietly stopped assuming that. Neutral bias, defensive tilt on duration.

The discovery is real. The 177% was forced buying. Own the science through Merck (MRK), not through the stampede.

We reinforced this two weeks ago. Chevron (CVX) keeps its weight. Williams (WMB) drops to watch, with a falsifier we wrote down.
The week belonged to the bond market. Treasury expanded its buybacks, and the ten-year closed at 4.737% anyway. The Journal’s Greg Ip explained why. Treasurys have gone from a safety premium to an absorption premium. Stock-market volatility stayed oddly calm (the VIX fell to 15.13) while positioning got violent. Biotechnology had a record short-covering day on Moderna’s 177% session, and a class of quant funds had its worst day in two years. Walmart’s slowest growth since 2020 said the consumer is careful, not gone. And the prediction markets quietly stopped pricing cuts. They put 86% odds on zero cuts in 2026, and one chance in three that September’s move is a hike.
Signals suggest the stock market is calm on the surface. The volatility index (VIX) sits at 15.13, and its term structure has held its normal, calm shape for months. Underneath, the bond market is doing the damage. Positioning is crowded, and it was punished twice this week. That combination argues for holding quality, setting a higher bar on new purchases, and owning the things that get paid if rates rise. Not a forecast; a posture.
Three triggers this week. If your bond ladder was built when the ten-year was under 2%, re-run it. If open enrollment is in your fall, decide plan design and the 401(k) contribution rate before the packet arrives. And if a single stock just handed you a year’s return in a day, ask what percentage of the plan it now is.